1-methyltryptophan has been researched along with Leukemia, Myeloid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aluigi, M; Baccarani, M; Curti, A; De Cristofaro, R; Evangelisti, C; Lemoli, RM; Ocadlikova, D; Onofri, C; Ottaviani, E; Rutella, S; Salvestrini, V; Trabanelli, S | 1 |
1 other study(ies) available for 1-methyltryptophan and Leukemia, Myeloid
Article | Year |
---|---|
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Topics: Acute Disease; Adult; Biocatalysis; Blotting, Western; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Coculture Techniques; Dendritic Cells; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; Immunophenotyping; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukemia, Myeloid; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes, Regulatory; Tryptophan; Tumor Cells, Cultured | 2010 |